Husch Blackwell’s Matt Kamps and Andrea Shoffstall were recently published by Marijuana Ventures in an article where they review U.S. cannabis-centric patents and patent applications trends during the pandemic, which were granted and published at record numbers in 2021. However, early returns in 2022 suggest the numbers may take a dip for the first time in years.

In addition, Kamps and Shoffstall examine cannabis-centric litigation at the federal level. Read more.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Matt Kamps Matt Kamps

Matt, as a registered patent attorney and intellectual property litigator, advocates for clients in patent litigation and post-grant proceedings, including litigation arising under the Hatch-Waxman Act. In addition to his litigation and post-grant practice, Matt has extensive experience developing global patent prosecution strategies…

Matt, as a registered patent attorney and intellectual property litigator, advocates for clients in patent litigation and post-grant proceedings, including litigation arising under the Hatch-Waxman Act. In addition to his litigation and post-grant practice, Matt has extensive experience developing global patent prosecution strategies, drafting legal opinions and licensing agreements, and performing patentability and freedom-to-operate analyses.

Photo of Andrea Shoffstall Andrea Shoffstall

Andrea enjoys supporting clients in the life sciences, telecommunications and technology sectors through intellectual property litigation.

A registered patent attorney, Andrea understands that intellectual property litigation can equal high-stakes outcomes. Not only are jobs and business-critical operations involved, but end-user and patient quality

Andrea enjoys supporting clients in the life sciences, telecommunications and technology sectors through intellectual property litigation.

A registered patent attorney, Andrea understands that intellectual property litigation can equal high-stakes outcomes. Not only are jobs and business-critical operations involved, but end-user and patient quality of life can also be at issue. Andrea believes IP litigation is part of a bigger picture and she’s passionate about finding solutions for clients.